Evaluating artificial intelligence-based cardiovascular magnetic resonance segmentation methods: Comparability to manual segmentation and impact on effect size and sample size in the TRED-HF trial

9 May 2026 (12:30 - 13:15)
Organised by: Logo
Congress Presentation Part of: Artificial intelligence in heart failure: detection, phenotyping, and monitoring Imaging HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by